J. Exp. Med.
© The Rockefeller University Press
0022-1007/96/12/2279/08 $2.00
Volume 184 December 1996 2279-2286

Antagonist HIV-1 Gag Peptides Induce Structural Changes in HLA B8

By Scott W. Reid,^* Steve McAdam, Kathrine J. Smith, Paul Klenerman, Chris A. O'Callaghan, Karl Harlos,^*§ Bent K. Jakobsen, Andrew J. McMichael, John I. Bell, David I. Stuart,^*§ and E. Yvonne Jones^*§

From the ^* Laboratory of Molecular Biophysics, The Rex Richards Building, Oxford OX1 3QU United Kingdom;  Molecular Immunology Group, Nuffield Department of Clinical Medicine, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU United Kingdom; and ^§ Oxford Centre for Molecular Sciences, New Chemistry Building, Oxford OX1 3QT United Kingdom

In the cellular immune response, recognition by CTL-TCRs of viral antigens presented as peptides by HLA class I molecules, triggers destruction of the virally infected cell (Townsend, A.R.M., J. Rothbard, F.M. Gotch, G. Bahadur, D. Wraith, and A.J. McMichael. 1986. Cell. 44:959-968). Altered peptide ligands (APLs) which antagonise CTL recognition of infected cells have been reported (Jameson, S.C., F.R. Carbone, and M.J. Bevan. 1993. J. Exp. Med. 177:1541-1550). In one example, lysis of antigen presenting cells by CTLs in response to recognition of an HLA B8-restricted HIV-1 P17 (aa 24-31) epitope can be inhibited by naturally occurring variants of this peptide, which act as TCR antagonists (Klenerman, P., S. Rowland Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R.E. Phillips, and A. McMichael. 1994. Nature (Lond.). 369:403- 407). We have characterised two CTL clones and a CTL line whose interactions with these variants of P17 (aa 24-31) exhibit a variety of responses. We have examined the high resolution crystal structures of four of these APLs in complex with HLA B8 to determine alterations in the shape, chemistry, and local flexibility of the TCR binding surface. The variant peptides cause changes in the recognition surface by three mechanisms: changes contributed directly by the peptide, effects transmitted to the exposed peptide surface, and induced effects on the exposed framework of the peptide binding groove. While the first two mechanisms frequently lead to antagonism, the third has more profound effects on TCR recognition.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• McCarthy, C., Shepherd, D., Fleire, S., Stronge, V. S., Koch, M., Illarionov, P. A., Bossi, G., Salio, M., Denkberg, G., Reddington, F., Tarlton, A., Reddy, B. G., Schmidt, R. R., Reiter, Y., Griffiths, G. M., van der Merwe, P. A., Besra, G. S., Jones, E. Y., Batista, F. D., Cerundolo, V. (2007). The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. JEM 204: 1131-1144 [Abstract] [Full Text]  
• Zimbwa, P., Milicic, A., Frater, J., Scriba, T. J., Willis, A., Goulder, P. J. R., Pillay, T., Gunthard, H., Weber, J. N., Zhang, H.-T., Phillips, R. E. (2007). Precise Identification of a Human Immunodeficiency Virus Type 1 Antigen Processing Mutant. J. Virol. 81: 2031-2038 [Abstract] [Full Text]  
• Negri, D. R. M., Borghi, M., Baroncelli, S., Macchia, I., Buffa, V., Sernicola, L., Leone, P., Titti, F., Cara, A. (2006). Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus.. J. Gen. Virol. 87: 3385-3392 [Abstract] [Full Text]  
• Turnbull, E. L., Lopes, A. R., Jones, N. A., Cornforth, D., Newton, P., Aldam, D., Pellegrino, P., Turner, J., Williams, I., Wilson, C. M., Goepfert, P. A., Maini, M. K., Borrow, P. (2006). HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently. J. Immunol. 176: 6130-6146 [Abstract] [Full Text]  
• Milicic, A., Edwards, C. T. T., Hue, S., Fox, J., Brown, H., Pillay, T., Drijfhout, J. W., Weber, J. N., Holmes, E. C., Fidler, S. J., Zhang, H.-T., Phillips, R. E. (2005). Sexual Transmission of Single Human Immunodeficiency Virus Type 1 Virions Encoding Highly Polymorphic Multisite Cytotoxic T-Lymphocyte Escape Variants. J. Virol. 79: 13953-13962 [Abstract] [Full Text]  
• Ely, L. K., Green, K. J., Beddoe, T., Clements, C. S., Miles, J. J., Bottomley, S. P., Zernich, D., Kjer-Nielsen, L., Purcell, A. W., McCluskey, J., Rossjohn, J., Burrows, S. R. (2005). Antagonism of Antiviral and Allogeneic Activity of a Human Public CTL Clonotype by a Single Altered Peptide Ligand: Implications for Allograft Rejection. J. Immunol. 174: 5593-5601 [Abstract] [Full Text]  
• Chen, J.-L., Stewart-Jones, G., Bossi, G., Lissin, N. M., Wooldridge, L., Choi, E. M. L., Held, G., Dunbar, P. R., Esnouf, R. M., Sami, M., Boulter, J. M., Rizkallah, P., Renner, C., Sewell, A., van der Merwe, P. A., Jakobsen, B. K., Griffiths, G., Jones, E. Y., Cerundolo, V. (2005). Structural and kinetic basis for heightened immunogenicity of T cell vaccines. JEM 201: 1243-1255 [Abstract] [Full Text]  
• Borbulevych, O. Y., Baxter, T. K., Yu, Z., Restifo, N. P., Baker, B. M. (2005). Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design. J. Immunol. 174: 4812-4820 [Abstract] [Full Text]  
• Barugahare, B., Baker, C., K'Aluoch, O., Donovan, R., Elrefaei, M., Eggena, M., Jones, N., Mutalya, S., Kityo, C., Mugyenyi, P., Cao, H. (2005). Human Immunodeficiency Virus-Specific Responses in Adult Ugandans: Patterns of Cross-Clade Recognition. J. Virol. 79: 4132-4139 [Abstract] [Full Text]  
• Dong, T., Stewart-Jones, G., Chen, N., Easterbrook, P., Xu, X., Papagno, L., Appay, V., Weekes, M., Conlon, C., Spina, C., Little, S., Screaton, G., van der Merwe, A., Richman, D. D., McMichael, A. J., Jones, E. Y., Rowland-Jones, S. L. (2004). HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor. JEM 200: 1547-1557 [Abstract] [Full Text]  
• Lee, J. K., Stewart-Jones, G., Dong, T., Harlos, K., Di Gleria, K., Dorrell, L., Douek, D. C., van der Merwe, P. A., Jones, E. Y., McMichael, A. J. (2004). T Cell Cross-Reactivity and Conformational Changes during TCR Engagement. JEM 200: 1455-1466 [Abstract] [Full Text]  
• Webb, A. I., Borg, N. A., Dunstone, M. A., Kjer-Nielsen, L., Beddoe, T., McCluskey, J., Carbone, F. R., Bottomley, S. P., Aguilar, M.-I., Purcell, A. W., Rossjohn, J. (2004). The Structure of H-2Kb and Kbm8 Complexed to a Herpes Simplex Virus Determinant: Evidence for a Conformational Switch That Governs T Cell Repertoire Selection and Viral Resistance. J. Immunol. 173: 402-409 [Abstract] [Full Text]  
• Webb, A. I., Dunstone, M. A., Chen, W., Aguilar, M.-I., Chen, Q., Jackson, H., Chang, L., Kjer-Nielsen, L., Beddoe, T., McCluskey, J., Rossjohn, J., Purcell, A. W. (2004). Functional and Structural Characteristics of NY-ESO-1-related HLA A2-restricted Epitopes and the Design of a Novel Immunogenic Analogue. J. Biol. Chem. 279: 23438-23446 [Abstract] [Full Text]  
• Velloso, L. M., Michaelsson, J., Ljunggren, H.-G., Schneider, G., Achour, A. (2004). Determination of Structural Principles Underlying Three Different Modes of Lymphocytic Choriomeningitis Virus Escape from CTL Recognition. J. Immunol. 172: 5504-5511 [Abstract] [Full Text]  
• Doytchinova, I. A., Guan, P., Flower, D. R. (2004). Identifiying Human MHC Supertypes Using Bioinformatic Methods. J. Immunol. 172: 4314-4323 [Abstract] [Full Text]  
• Hulsmeyer, M., Fiorillo, M. T., Bettosini, F., Sorrentino, R., Saenger, W., Ziegler, A., Uchanska-Ziegler, B. (2004). Dual, HLA-B27 Subtype-dependent Conformation of a Self-peptide. JEM 199: 271-281 [Abstract] [Full Text]  
• Kjer-Nielsen, L., Clements, C. S., Brooks, A. G., Purcell, A. W., Fontes, M. R., McCluskey, J., Rossjohn, J. (2002). The Structure of HLA-B8 Complexed to an Immunodominant Viral Determinant: Peptide-Induced Conformational Changes and a Mode of MHC Class I Dimerization. J. Immunol. 169: 5153-5160 [Abstract] [Full Text]  
• Ogata, K., Wodak, S. J. (2002). Conserved water molecules in MHC class-I molecules and their putative structural and functional roles. Protein Eng Des Sel 15: 697-705 [Abstract] [Full Text]  
• McMichael, A., Mwau, M., Hanke, T. (2002). Design and tests of an HIV vaccine. Br Med Bull 62: 87-98 [Abstract] [Full Text]  
• Hennecke, J., Wiley, D. C. (2002). Structure of a Complex of the Human {alpha}/{beta} T Cell Receptor (TCR) HA1.7, Influenza Hemagglutinin Peptide, and Major Histocompatibility Complex Class II Molecule, HLA-DR4 (DRA0101 and DRB10401): Insight into TCR Cross-Restriction and Alloreactivity. JEM 195: 571-581 [Abstract] [Full Text]  
• Buslepp, J., Zhao, R., Donnini, D., Loftus, D., Saad, M., Appella, E., Collins, E. J. (2001). T Cell Activity Correlates with Oligomeric Peptide-Major Histocompatibility Complex Binding on T Cell Surface. J. Biol. Chem. 276: 47320-47328 [Abstract] [Full Text]  
• Messaoudi, I., LeMaoult, J., Metzner, B. M., Miley, M. J., Fremont, D. H., Nikolich-Zugich, J. (2001). Functional Evidence That Conserved TCR CDR{{alpha}}3 Loop Docking Governs the Cross-Recognition of Closely Related Peptide:Class I Complexes. J. Immunol. 167: 836-843 [Abstract] [Full Text]  
• Thomson, C. T., Kalergis, A. M., Sacchettini, J. C., Nathenson, S. G. (2001). A Structural Difference Limited to One Residue of the Antigenic Peptide Can Profoundly Alter the Biological Outcome of the TCR-Peptide/MHC Class I Interaction. J. Immunol. 166: 3994-3997 [Abstract] [Full Text]  
• Micheletti, F., Canella, A., Vertuani, S., Marastoni, M., Tosi, L., Volinia, S., Traniello, S., Gavioli, R. (2000). Supra-Agonist Peptides Enhance the Reactivation of Memory CTL Responses. J. Immunol. 165: 4264-4271 [Abstract] [Full Text]  
• Maenaka, K., Maenaka, T., Tomiyama, H., Takiguchi, M., Stuart, D. I., Jones, E. Y. (2000). Nonstandard Peptide Binding Revealed by Crystal Structures of HLA-B*5101 Complexed with HIV Immunodominant Epitopes. J. Immunol. 165: 3260-3267 [Abstract] [Full Text]  
• Voeten, J. T. M., Bestebroer, T. M., Nieuwkoop, N. J., Fouchier, R. A. M., Osterhaus, A. D. M. E., Rimmelzwaan, G. F. (2000). Antigenic Drift in the Influenza A Virus (H3N2) Nucleoprotein and Escape from Recognition by Cytotoxic T Lymphocytes. J. Virol. 74: 6800-6807 [Abstract] [Full Text]  
• Wingren, C., Crowley, M. P., Degano, I. S. A. M., Chien, Y., Wilson, I. A. (2000). Crystal Structure of a T Cell Receptor Ligand T22: A Truncated MHC-Like Fold. Science 287: 310-314 [Abstract] [Full Text]  
• Kalergis, A. M., Ono, T., Wang, F., DiLorenzo, T. P., Honda, S., Nathenson, S. G. (1999). Single Amino Acid Replacements in an Antigenic Peptide Are Sufficient to Alter the TCR V{beta} Repertoire of the Responding CD8+ Cytotoxic Lymphocyte Population. J. Immunol. 162: 7263-7270 [Abstract] [Full Text]  
• Saito, N. G., Chang, H.-C., Paterson, Y. (1999). Recognition of an MHC Class I-Restricted Antigenic Peptide Can Be Modulated by para-Substitution of Its Buried Tyrosine Residues in a TCR-Specific Manner. J. Immunol. 162: 5998-6008 [Abstract] [Full Text]  
• Matsuo, H., Corlett, L., Hawke, S., Nicolle, M., Driscoll, P., Deshpande, S., Spack, E., Willcox, N. (1999). Distant interactions between dimorphisms in HLA-DR4 radically affect recognition of defined peptides by a specific T cell clone. Int Immunol 11: 835-843 [Abstract] [Full Text]  
• Ono, T., DiLorenzo, T. P., Wang, F., Kalergis, A. M., Nathenson, S. G. (1998). Alterations in TCR-MHC Contacts Subsequent to Cross-Recognition of Class I MHC and Singly Substituted Peptide Variants. J. Immunol. 161: 5454-5463 [Abstract] [Full Text]  
• Ghendler, Y., Teng, M.-k., Liu, J.-h., Witte, T., Liu, J., Kim, K. S., Kern, P., Chang, H.-C., Wang, J.-h., Reinherz, E. L. (1998). Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands. Proc. Natl. Acad. Sci. USA 95: 10061-10066 [Abstract] [Full Text]  
• McMichael, A. J., O'Callaghan, C. A. (1998). A New Look at T Cells. JEM 187: 1367-1371 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS